| Net Cash Provided by (Used in) Operating Activities |
$28,000 |
USD |
-115% |
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$0 |
USD |
|
Q4 2024 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$0 |
USD |
|
Q4 2024 |
Q1 2025 |
| Common Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
11,187,640 |
shares |
-0.37% |
Q3 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$2,545,000 |
USD |
-4.2% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Valuation Allowance |
$847,000 |
USD |
5.1% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$847,000 |
USD |
5.1% |
Q3 2025 |
FY 2025 |
| Operating Lease, Liability |
$28,800 |
USD |
31% |
Q3 2025 |
FY 2025 |
| Operating Lease, Liability, Current |
$26,000 |
USD |
24% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$418,000 |
USD |
5.8% |
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
FY 2025 |
| Preferred Stock, Shares Authorized |
5,000,000 |
shares |
0% |
Q3 2025 |
FY 2025 |
| Additional Paid in Capital |
$13,681,000 |
USD |
-0.09% |
Q3 2025 |
FY 2025 |
| Depreciation, Depletion and Amortization |
$3,000 |
USD |
-25% |
Q3 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$0 |
USD |
|
Q3 2025 |
FY 2025 |
| Preferred Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q3 2025 |
FY 2025 |